255 related articles for article (PubMed ID: 19118225)
1. Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
Eur Respir J; 2009 Jan; 33(1):118-26. PubMed ID: 19118225
[TBL] [Abstract][Full Text] [Related]
2. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
PLoS One; 2011; 6(7):e21874. PubMed ID: 21799753
[TBL] [Abstract][Full Text] [Related]
3. Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer.
Jackute J; Zemaitis M; Pranys D; Sitkauskiene B; Miliauskas S; Vaitkiene S; Sakalauskas R
BMC Immunol; 2018 Jan; 19(1):3. PubMed ID: 29361917
[TBL] [Abstract][Full Text] [Related]
4. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time.
Ma J; Liu L; Che G; Yu N; Dai F; You Z
BMC Cancer; 2010 Mar; 10():112. PubMed ID: 20338029
[TBL] [Abstract][Full Text] [Related]
5. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.
Welsh TJ; Green RH; Richardson D; Waller DA; O'Byrne KJ; Bradding P
J Clin Oncol; 2005 Dec; 23(35):8959-67. PubMed ID: 16219934
[TBL] [Abstract][Full Text] [Related]
6. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
BMC Cancer; 2010 Jun; 10():323. PubMed ID: 20573209
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated neutrophils and macrophages in non-small cell lung cancer: no immediate impact on patient outcome.
Carus A; Ladekarl M; Hager H; Pilegaard H; Nielsen PS; Donskov F
Lung Cancer; 2013 Jul; 81(1):130-7. PubMed ID: 23540719
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.
Miotto D; Lo Cascio N; Stendardo M; Querzoli P; Pedriali M; De Rosa E; Fabbri LM; Mapp CE; Boschetto P
Lung Cancer; 2010 Sep; 69(3):355-60. PubMed ID: 20089329
[TBL] [Abstract][Full Text] [Related]
12. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer.
Pei BX; Sun BS; Zhang ZF; Wang AL; Ren P
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1208-1216.e2. PubMed ID: 24907005
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
14. Mast cell phenotype, TNFα expression and degranulation status in non-small cell lung cancer.
Shikotra A; Ohri CM; Green RH; Waller DA; Bradding P
Sci Rep; 2016 Dec; 6():38352. PubMed ID: 27922077
[TBL] [Abstract][Full Text] [Related]
15. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
BMC Cancer; 2010 Apr; 10():172. PubMed ID: 20429924
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
18. Detection of M2-macrophages in uveal melanoma and relation with survival.
Bronkhorst IH; Ly LV; Jordanova ES; Vrolijk J; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):643-50. PubMed ID: 20811059
[TBL] [Abstract][Full Text] [Related]
19. Spatial interaction and functional status of CD68
Liu X; Zhang Z; Yuan J; Yu J; Chen D
Front Immunol; 2024; 15():1396719. PubMed ID: 38799432
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
